Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Neurology
|
April 22, 2024
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis
Robert J Fox, Bruce A C Cree, Jérôme de Sèze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 27, 2025
Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial
Peter A Calabresi, Gavin Giovannoni, Hans-Peter Hartung, et al.
Annals of Clinical and Translational Neurology
|
November 25, 2022
Associations of sNfL with clinico-radiological measures in a large MS population
Elias S Sotirchos, Kathryn C Fitzgerald, Carol M Singh, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
<i>APOE-</i> ε4-induced Fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer's disease
Prabesh Bhattarai, Elanur Yilmaz, Elif Öykü Cakir, et al.
Frontiers in Neurology
|
August 28, 2020
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)
Ellen M Mowry, Robert A Bermel, James R Williams, et al.
The Lancet. Oncology
|
April 30, 2026
Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial
Seth A Wander, Maxwell R Lloyd, Jennifer C Keenan, et al.
Neuromolecular Medicine
|
January 5, 2025
Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society
Lisi Flores-Aguilar, Eric D Hamlett, Paula Araya, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
Assigning Targetable Molecular Pathways to Transdiagnostic Subgroups Across Autism and Related Neurodevelopmental Disorders
Jacob Ellegood, Antoine Beauchamp, Yohan Yee, et al.
Nature Genetics
|
August 17, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics
|
March 2, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Neurology
|
April 22, 2024
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis
Robert J Fox, Bruce A C Cree, Jérôme de Sèze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 27, 2025
Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial
Peter A Calabresi, Gavin Giovannoni, Hans-Peter Hartung, et al.
Annals of Clinical and Translational Neurology
|
November 25, 2022
Associations of sNfL with clinico-radiological measures in a large MS population
Elias S Sotirchos, Kathryn C Fitzgerald, Carol M Singh, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
<i>APOE-</i> ε4-induced Fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer's disease
Prabesh Bhattarai, Elanur Yilmaz, Elif Öykü Cakir, et al.
Frontiers in Neurology
|
August 28, 2020
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)
Ellen M Mowry, Robert A Bermel, James R Williams, et al.
The Lancet. Oncology
|
April 30, 2026
Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial
Seth A Wander, Maxwell R Lloyd, Jennifer C Keenan, et al.
Neuromolecular Medicine
|
January 5, 2025
Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society
Lisi Flores-Aguilar, Eric D Hamlett, Paula Araya, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
Assigning Targetable Molecular Pathways to Transdiagnostic Subgroups Across Autism and Related Neurodevelopmental Disorders
Jacob Ellegood, Antoine Beauchamp, Yohan Yee, et al.
Nature Genetics
|
August 17, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics
|
March 2, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Page
of 10